Recently, a potential marker (IL-27) has been proposed to distinguish between early-onset FPIES and NEC [30], and biomarkers for inflammatory bowel diseases are also currently being investigated in ongoing studies [31,32,33]. The gene discussed is IL27; the disease is inflammatory bowel disease.